#Germany #Medical Devices #Putzbrunn #portal hypertension #GORE VIATORR TIPS

GORE® VIATORR® TIPS Endoprosthesis

In a significant development for the treatment of portal hypertension, W. L. Gore & Associates Medical Products has secured CE mark approval for its new GORE® VIATORR® TIPS Endoprosthesis, featuring a modified diameter range of 6 to 10 mm. This adaptation marks a pivotal enhancement in their innovative offerings aimed at improving patient outcomes in the management of portal hypertension, a condition where blood pressure increases in the portal venous system.

A Legacy of Innovation

The GORE® VIATORR® TIPS Endoprosthesis has long been a go-to solution for clinicians, having redefined treatment methods over more than 25 years. The introduction of this new diameter range provides healthcare professionals with an increased ability to customize treatment plans according to individual patient requirements. As noted by Professor Filippo Schepis of the University Hospital of Modena, optimizing the shunt diameter is essential to minimize risks like hepatic encephalopathy and cardiac overload, conditions that significantly hinder patient quality of life.

Controlled Expansion Technology

The core of the GORE® VIATORR® TIPS innovation lies in its controlled expansion technology. This technology enables precise tailoring of shunt sizes, allowing for a targeted portal pressure gradient. Clinicians can now balance the need for effective portal pressure reduction with the crucial awareness of avoiding complications from over-shunting. This newly approved device, which builds upon the previously existing 8-10 mm options, allows practitioners nuanced control that was previously unavailable.

Roberto Miraglia from ISMETT in Palermo, Italy, emphasizes that the clinical integration of varied diameter options within a single device represents a transformative step toward optimal patient management. With data supporting the efficacy of smaller diameter devices in decreasing complications, this advancement holds promise for those affected by portal hypertension.

Proven Performance

The GORE® VIATORR® Device stands out as the only covered TIPS device boasting over two decades of clinical efficacy with extensive research backing its reliability and patency. With the adoption of Gore's proprietary ePTFE graft lining, it effectively resists the permeation of bile and mucin—common culprits of patency loss in TIPS procedures. Through rigorous studies, the device has shown to sustain function over time, providing both doctors and patients confidence in its use.

Benefits for Healthcare Professionals

The controlled expansion technology not only enriches the implantation phase but also supplies physicians with expanded options without the burden of managing increased inventory. This streamlining is particularly beneficial in settings where efficiency and resource management are paramount. Thomas Wiersma, EMEA Product Specialist at Gore, attests to the broadening of choices available to healthcare providers, enabling them to better tailor their approaches to shunting procedures.

Gore’s commitment to medical innovation, coupled with research-driven insights, positions the GORE® VIATORR® TIPS Endoprosthesis with Controlled Expansion at the forefront of modern therapeutic strategies. Healthcare practitioners interested in exploring this device further can access detailed outcomes and comparative analyses on Gore’s dedicated medical product website.

Conclusion

With over 55 million medical devices implanted globally, Gore continues to impact patient lives positively through groundbreaking technology and collaborative expertise with medical professionals. Their ongoing strides in enhancing cardiovascular health underscore the vital importance of innovation in medical treatments. For further insights into the GORE® VIATORR® Device and its implications for portal hypertension therapy, please visit Gore Medical.